Business

Appointment of CEO

Appointment of CEO.

articleIofina PlcSeptember 5, 20144/company/iofina-plc/news/appointment-of-ceo-68
Appointment of CEO

About this update from Iofina Plc

[{"type":"text","content":"\n \nRNS Number : 9114Q Iofina PLC 05 September 2014  \n\n \nSeptember 5, 2014\nIofina plc\n(\"Iofina\" or the \"Company\")\n(LSE AIM: IOF)\n \nAppointment of CEO\n \nIofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce the appointment of Dr. Thomas M. Becker as President & CEO of the Company effective immediately. Company co-founder Mr. Jeffery Ploen, will return to his role as Non-Executive Director.\n \nDr. Becker is a current Executive Director of the Company and the President/CEO of Iofina Chemical, Inc. Under his four years of management, Iofina Chemical has experienced record expansion, revenues and profits.  Dr. Becker is a recognized expert in the global iodine market and has extensive production knowledge of iodine and iodine derivatives. Dr. Becker holds a PhD from the University of Cincinnati and a BS from Indiana University, both in Chemistry. \n \nLance J Baller, co-founder and Non-Executive Chairman commented: \"Tom has shown he is the ideal candidate to lead Iofina through its next stage of development.  His proven success at Iofina Chemical and extensive knowledge and connections within the global iodine industry are well recognised.  Tom's leadership will guide Iofina forward as we continue to grow and optimize our company-wide operations.\"\n \n \nFor further information, please contact:\n \nLance Baller, Non-Executive Chairman\nDr. Tom Becker, President & CEO\nIofina\nTel: +44 (0) 20 3006 3135\n \nJohn Prior/Rupert Krefting/Paul Gillam\nNumis Securities\nTel: +44 (0)20 7260 1000\n \nRob Collins/Emily Morris/Liz Williamson\nGMP Securities\nTel: +44(0)20 7647 2800\n \nDominic Barretto/Anna Legge\nYellow Jersey PR\nTel: +44 (0)7768 537 739\n \n \n \nAbout Iofina:\n \nIofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Texas, Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of io...

More updates from Iofina Plc